Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glutathione Transferase | 6 | 2011 | 565 | 1.820 |
Why?
|
Laparoscopy | 11 | 2023 | 2036 | 1.760 |
Why?
|
Glutathione S-Transferase pi | 5 | 2010 | 99 | 1.470 |
Why?
|
Polymorphism, Genetic | 11 | 2012 | 4243 | 1.460 |
Why?
|
Adrenalectomy | 5 | 2016 | 346 | 1.430 |
Why?
|
Peritoneal Dialysis | 2 | 2021 | 159 | 1.340 |
Why?
|
Peritonitis | 2 | 2021 | 368 | 1.240 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2012 | 15936 | 1.020 |
Why?
|
Alkaline Phosphatase | 7 | 2017 | 864 | 1.020 |
Why?
|
Gastric Bypass | 3 | 2021 | 818 | 0.950 |
Why?
|
Obesity, Morbid | 4 | 2021 | 1277 | 0.920 |
Why?
|
Cytochrome P-450 CYP1A1 | 4 | 2012 | 90 | 0.900 |
Why?
|
Urinary Retention | 1 | 2023 | 106 | 0.820 |
Why?
|
Meta-Analysis as Topic | 7 | 2011 | 1380 | 0.820 |
Why?
|
Codon | 4 | 2010 | 601 | 0.780 |
Why?
|
Aortic Aneurysm, Abdominal | 6 | 2018 | 1228 | 0.740 |
Why?
|
Hernia, Inguinal | 1 | 2023 | 220 | 0.710 |
Why?
|
Breast Neoplasms | 14 | 2020 | 21019 | 0.690 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2011 | 2917 | 0.680 |
Why?
|
Bariatric Surgery | 2 | 2021 | 992 | 0.680 |
Why?
|
Caspase 8 | 2 | 2010 | 190 | 0.670 |
Why?
|
Endometriosis | 5 | 2020 | 870 | 0.640 |
Why?
|
Genes, p53 | 3 | 2010 | 712 | 0.620 |
Why?
|
Refugees | 2 | 2016 | 596 | 0.610 |
Why?
|
Blood Vessel Prosthesis Implantation | 9 | 2018 | 1428 | 0.610 |
Why?
|
Endometrial Neoplasms | 3 | 2020 | 1366 | 0.590 |
Why?
|
Cytochrome P-450 Enzyme System | 2 | 2010 | 412 | 0.590 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2010 | 368 | 0.580 |
Why?
|
Cholelithiasis | 1 | 2019 | 407 | 0.570 |
Why?
|
Cardioplegic Solutions | 1 | 2017 | 123 | 0.570 |
Why?
|
Cicatrix | 3 | 2012 | 798 | 0.570 |
Why?
|
Endarterectomy, Carotid | 3 | 2011 | 555 | 0.560 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2017 | 34 | 0.560 |
Why?
|
Carcinoma, Endometrioid | 1 | 2020 | 276 | 0.560 |
Why?
|
Genetic Predisposition to Disease | 16 | 2012 | 17904 | 0.560 |
Why?
|
Cholecystectomy | 1 | 2019 | 406 | 0.550 |
Why?
|
Carotid Stenosis | 4 | 2011 | 860 | 0.540 |
Why?
|
Stents | 9 | 2018 | 3179 | 0.530 |
Why?
|
Mullerian Ducts | 1 | 2017 | 203 | 0.530 |
Why?
|
Genital Neoplasms, Female | 2 | 2020 | 532 | 0.530 |
Why?
|
Heart Injuries | 1 | 2018 | 206 | 0.520 |
Why?
|
Heart Arrest, Induced | 1 | 2017 | 358 | 0.520 |
Why?
|
Parathyroidectomy | 3 | 2012 | 242 | 0.510 |
Why?
|
Anti-Bacterial Agents | 4 | 2019 | 7406 | 0.500 |
Why?
|
Adrenal Gland Diseases | 2 | 2016 | 141 | 0.500 |
Why?
|
Vascular Surgical Procedures | 2 | 2015 | 1489 | 0.500 |
Why?
|
Umbilicus | 1 | 2015 | 36 | 0.500 |
Why?
|
Carotid Body Tumor | 1 | 2015 | 34 | 0.490 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2020 | 2020 | 0.490 |
Why?
|
Gallbladder Diseases | 1 | 2016 | 141 | 0.480 |
Why?
|
Azithromycin | 1 | 2016 | 199 | 0.470 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2016 | 232 | 0.450 |
Why?
|
Thyroidectomy | 4 | 2016 | 908 | 0.440 |
Why?
|
Appendectomy | 1 | 2017 | 433 | 0.440 |
Why?
|
Urologic Diseases | 1 | 2016 | 247 | 0.430 |
Why?
|
Urologic Surgical Procedures | 1 | 2016 | 298 | 0.430 |
Why?
|
Interprofessional Relations | 2 | 2015 | 990 | 0.380 |
Why?
|
Ovarian Neoplasms | 5 | 2020 | 4878 | 0.380 |
Why?
|
Foreign Medical Graduates | 1 | 2012 | 77 | 0.370 |
Why?
|
Endovascular Procedures | 4 | 2018 | 2183 | 0.370 |
Why?
|
Humans | 106 | 2023 | 761596 | 0.370 |
Why?
|
Surgery, Plastic | 1 | 2018 | 643 | 0.370 |
Why?
|
Uterine Monitoring | 1 | 2010 | 3 | 0.360 |
Why?
|
Colorectal Neoplasms | 4 | 2011 | 6938 | 0.360 |
Why?
|
Intestinal Mucosa | 3 | 2016 | 3032 | 0.360 |
Why?
|
Appendicitis | 1 | 2017 | 675 | 0.350 |
Why?
|
Genetics | 1 | 2010 | 114 | 0.350 |
Why?
|
Robotics | 1 | 2016 | 819 | 0.340 |
Why?
|
Fertility Agents, Female | 2 | 2009 | 101 | 0.340 |
Why?
|
Parathyroid Glands | 1 | 2012 | 518 | 0.340 |
Why?
|
Medically Underserved Area | 1 | 2012 | 254 | 0.340 |
Why?
|
Abnormalities, Multiple | 1 | 2017 | 1423 | 0.330 |
Why?
|
Greece | 5 | 2016 | 340 | 0.330 |
Why?
|
Hepatic Encephalopathy | 1 | 2010 | 144 | 0.330 |
Why?
|
Esthetics | 1 | 2011 | 330 | 0.330 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2010 | 95 | 0.330 |
Why?
|
Pregnancy Complications | 2 | 2016 | 2947 | 0.330 |
Why?
|
Workplace | 1 | 2015 | 863 | 0.320 |
Why?
|
Luteal Phase | 1 | 2009 | 138 | 0.320 |
Why?
|
Mentors | 1 | 2014 | 661 | 0.320 |
Why?
|
Dietary Supplements | 3 | 2017 | 3415 | 0.320 |
Why?
|
Cyclin D1 | 1 | 2010 | 451 | 0.310 |
Why?
|
Risk Factors | 28 | 2021 | 74213 | 0.310 |
Why?
|
Carcinoma | 4 | 2015 | 2330 | 0.310 |
Why?
|
General Surgery | 3 | 2014 | 1692 | 0.310 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1403 | 0.310 |
Why?
|
Catheters, Indwelling | 2 | 2021 | 426 | 0.310 |
Why?
|
Esophageal and Gastric Varices | 1 | 2010 | 208 | 0.310 |
Why?
|
Ovarian Follicle | 1 | 2009 | 244 | 0.290 |
Why?
|
Length of Stay | 9 | 2020 | 6426 | 0.290 |
Why?
|
Leuprolide | 1 | 2009 | 312 | 0.290 |
Why?
|
Infertility, Male | 1 | 2010 | 395 | 0.280 |
Why?
|
Odds Ratio | 10 | 2018 | 9647 | 0.270 |
Why?
|
Fluoroquinolones | 2 | 2019 | 307 | 0.260 |
Why?
|
International Cooperation | 1 | 2012 | 1422 | 0.250 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1418 | 0.250 |
Why?
|
Thyroid Gland | 1 | 2012 | 1170 | 0.240 |
Why?
|
Crohn Disease | 1 | 2017 | 2279 | 0.240 |
Why?
|
Thiazolidinediones | 1 | 2008 | 461 | 0.240 |
Why?
|
Fertilization in Vitro | 2 | 2009 | 1292 | 0.230 |
Why?
|
Female | 56 | 2021 | 392705 | 0.230 |
Why?
|
Oocytes | 1 | 2009 | 1166 | 0.230 |
Why?
|
Gene Frequency | 5 | 2012 | 3606 | 0.230 |
Why?
|
Health Policy | 1 | 2016 | 2684 | 0.230 |
Why?
|
Postoperative Complications | 9 | 2023 | 15633 | 0.220 |
Why?
|
Gastrectomy | 2 | 2021 | 672 | 0.220 |
Why?
|
Treatment Outcome | 23 | 2021 | 64685 | 0.220 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2010 | 696 | 0.220 |
Why?
|
Public Health | 1 | 2016 | 2669 | 0.220 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2010 | 1116 | 0.210 |
Why?
|
Angioplasty | 3 | 2010 | 355 | 0.210 |
Why?
|
Cardiac Surgical Procedures | 2 | 2020 | 3627 | 0.210 |
Why?
|
Tissue Scaffolds | 2 | 2021 | 934 | 0.210 |
Why?
|
Cholangiocarcinoma | 2 | 2021 | 552 | 0.210 |
Why?
|
DNA-Binding Proteins | 2 | 2010 | 9610 | 0.210 |
Why?
|
Bile Duct Neoplasms | 2 | 2021 | 605 | 0.210 |
Why?
|
Contraceptives, Oral | 2 | 2015 | 554 | 0.210 |
Why?
|
Case-Control Studies | 10 | 2012 | 22176 | 0.200 |
Why?
|
Pandemics | 1 | 2022 | 8656 | 0.200 |
Why?
|
Thyroid Neoplasms | 4 | 2016 | 2332 | 0.190 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5314 | 0.190 |
Why?
|
Aluminum | 1 | 2022 | 152 | 0.190 |
Why?
|
Obesity | 4 | 2016 | 12947 | 0.190 |
Why?
|
Patient Isolation | 1 | 2022 | 100 | 0.190 |
Why?
|
Xanthomatosis | 1 | 2021 | 32 | 0.190 |
Why?
|
Homozygote | 3 | 2010 | 1776 | 0.180 |
Why?
|
Communication | 1 | 2015 | 3875 | 0.180 |
Why?
|
Smoking | 1 | 2018 | 9053 | 0.180 |
Why?
|
Hypopharyngeal Neoplasms | 1 | 2021 | 51 | 0.180 |
Why?
|
Research Design | 3 | 2010 | 6180 | 0.180 |
Why?
|
Cholecystitis | 1 | 2021 | 180 | 0.170 |
Why?
|
Liver Cirrhosis | 1 | 2010 | 1935 | 0.170 |
Why?
|
Stomach Neoplasms | 1 | 2010 | 1459 | 0.170 |
Why?
|
Alleles | 1 | 2010 | 6864 | 0.170 |
Why?
|
Genotype | 6 | 2012 | 12990 | 0.160 |
Why?
|
Aerosols | 1 | 2022 | 635 | 0.160 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5790 | 0.160 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 2 | 2010 | 244 | 0.160 |
Why?
|
Risk | 5 | 2017 | 9610 | 0.160 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5440 | 0.160 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2011 | 2223 | 0.150 |
Why?
|
Embolic Protection Devices | 1 | 2017 | 42 | 0.150 |
Why?
|
Duodenum | 1 | 2021 | 490 | 0.150 |
Why?
|
Time Factors | 11 | 2021 | 39969 | 0.140 |
Why?
|
Isotonic Solutions | 1 | 2017 | 117 | 0.140 |
Why?
|
beta-Lactams | 1 | 2019 | 155 | 0.140 |
Why?
|
Anastomosis, Surgical | 1 | 2021 | 983 | 0.140 |
Why?
|
Cushing Syndrome | 2 | 2016 | 241 | 0.140 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2017 | 36 | 0.140 |
Why?
|
Patient Selection | 7 | 2015 | 4244 | 0.140 |
Why?
|
Endometrium | 1 | 2020 | 403 | 0.140 |
Why?
|
Aspartame | 1 | 2016 | 19 | 0.140 |
Why?
|
Hyperandrogenism | 1 | 2017 | 39 | 0.140 |
Why?
|
Tetracycline | 1 | 2017 | 216 | 0.140 |
Why?
|
Hepatectomy | 1 | 2020 | 557 | 0.140 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2020 | 451 | 0.140 |
Why?
|
Carcinoma, Papillary | 3 | 2016 | 785 | 0.140 |
Why?
|
Acholeplasma | 1 | 2016 | 4 | 0.140 |
Why?
|
Intracranial Embolism | 1 | 2017 | 189 | 0.130 |
Why?
|
Risk Assessment | 11 | 2021 | 23996 | 0.130 |
Why?
|
Metronidazole | 1 | 2017 | 232 | 0.130 |
Why?
|
Male | 35 | 2021 | 360846 | 0.130 |
Why?
|
Weaning | 1 | 2016 | 103 | 0.130 |
Why?
|
Blood Vessel Prosthesis | 3 | 2010 | 951 | 0.130 |
Why?
|
Economic Recession | 1 | 2016 | 79 | 0.130 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2016 | 241 | 0.130 |
Why?
|
European Union | 1 | 2016 | 157 | 0.130 |
Why?
|
Bacteroides | 1 | 2016 | 165 | 0.130 |
Why?
|
Molecular Typing | 1 | 2016 | 116 | 0.130 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13381 | 0.130 |
Why?
|
Catheterization | 1 | 2021 | 1428 | 0.130 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2015 | 108 | 0.130 |
Why?
|
Laparotomy | 2 | 2015 | 457 | 0.120 |
Why?
|
Sexual Maturation | 1 | 2017 | 261 | 0.120 |
Why?
|
Tissue Adhesions | 1 | 2016 | 218 | 0.120 |
Why?
|
Pregnancy | 4 | 2016 | 29890 | 0.120 |
Why?
|
Colitis, Ulcerative | 2 | 2017 | 1922 | 0.120 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 3085 | 0.120 |
Why?
|
Blood | 1 | 2017 | 596 | 0.120 |
Why?
|
Femoral Artery | 2 | 2009 | 826 | 0.120 |
Why?
|
Vascular Patency | 3 | 2013 | 911 | 0.120 |
Why?
|
Educational Technology | 1 | 2014 | 59 | 0.120 |
Why?
|
Teaching Materials | 1 | 2014 | 84 | 0.120 |
Why?
|
Pain, Postoperative | 2 | 2023 | 1740 | 0.120 |
Why?
|
Penicillins | 1 | 2017 | 402 | 0.120 |
Why?
|
Contraceptive Agents | 1 | 2015 | 144 | 0.110 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 2015 | 305 | 0.110 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2015 | 116 | 0.110 |
Why?
|
Cachexia | 1 | 2015 | 202 | 0.110 |
Why?
|
Gynecology | 1 | 2020 | 526 | 0.110 |
Why?
|
Middle Aged | 23 | 2021 | 220921 | 0.110 |
Why?
|
Nephrectomy | 2 | 2016 | 937 | 0.110 |
Why?
|
Adult | 18 | 2021 | 221210 | 0.110 |
Why?
|
Blood Chemical Analysis | 1 | 2015 | 437 | 0.110 |
Why?
|
Hand-Assisted Laparoscopy | 1 | 2013 | 15 | 0.110 |
Why?
|
Transients and Migrants | 1 | 2016 | 165 | 0.110 |
Why?
|
Ureter | 1 | 2016 | 368 | 0.110 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2020 | 946 | 0.110 |
Why?
|
Health Care Costs | 3 | 2015 | 3242 | 0.110 |
Why?
|
Uterus | 1 | 2017 | 649 | 0.110 |
Why?
|
Iodine Radioisotopes | 1 | 2016 | 1031 | 0.110 |
Why?
|
Mass Casualty Incidents | 1 | 2015 | 179 | 0.110 |
Why?
|
Heterozygote | 2 | 2010 | 2787 | 0.110 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2014 | 296 | 0.100 |
Why?
|
Cattle | 2 | 2016 | 3849 | 0.100 |
Why?
|
Fournier Gangrene | 1 | 2012 | 22 | 0.100 |
Why?
|
School Health Services | 1 | 2016 | 384 | 0.100 |
Why?
|
Glucose Intolerance | 1 | 2016 | 575 | 0.100 |
Why?
|
Hyperaldosteronism | 1 | 2015 | 247 | 0.100 |
Why?
|
Brucella abortus | 1 | 2012 | 14 | 0.100 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2017 | 594 | 0.100 |
Why?
|
Drama | 1 | 2012 | 15 | 0.100 |
Why?
|
Gastrointestinal Agents | 1 | 2017 | 510 | 0.100 |
Why?
|
Feces | 2 | 2016 | 1497 | 0.100 |
Why?
|
Genital Diseases, Male | 1 | 2012 | 83 | 0.100 |
Why?
|
Intergenerational Relations | 1 | 2012 | 67 | 0.100 |
Why?
|
Brucellosis | 1 | 2012 | 21 | 0.100 |
Why?
|
Renal Insufficiency | 2 | 2015 | 809 | 0.100 |
Why?
|
Medicine in Literature | 1 | 2012 | 32 | 0.100 |
Why?
|
Popliteal Artery | 2 | 2011 | 310 | 0.100 |
Why?
|
Polysaccharides | 1 | 2018 | 1014 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4111 | 0.100 |
Why?
|
Vagina | 1 | 2017 | 838 | 0.100 |
Why?
|
Lung Transplantation | 1 | 2021 | 1310 | 0.090 |
Why?
|
Aged | 19 | 2021 | 169310 | 0.090 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12690 | 0.090 |
Why?
|
Carotid Artery Diseases | 1 | 2017 | 877 | 0.090 |
Why?
|
Famous Persons | 1 | 2012 | 109 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2023 | 80647 | 0.090 |
Why?
|
Consensus | 1 | 2021 | 3124 | 0.090 |
Why?
|
Video-Assisted Surgery | 1 | 2011 | 51 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2019 | 58984 | 0.090 |
Why?
|
Paraparesis | 1 | 2010 | 15 | 0.090 |
Why?
|
Heparin | 1 | 2018 | 1634 | 0.090 |
Why?
|
Fertility Agents | 1 | 2010 | 11 | 0.090 |
Why?
|
Blood Loss, Surgical | 1 | 2015 | 638 | 0.090 |
Why?
|
Syndrome | 1 | 2017 | 3267 | 0.090 |
Why?
|
Extracellular Matrix | 1 | 2018 | 1726 | 0.090 |
Why?
|
Mice, Inbred C57BL | 7 | 2017 | 22174 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1654 | 0.090 |
Why?
|
Models, Genetic | 2 | 2010 | 3442 | 0.090 |
Why?
|
Biocompatible Materials | 1 | 2018 | 1685 | 0.090 |
Why?
|
Intraoperative Complications | 1 | 2016 | 1166 | 0.090 |
Why?
|
Paraplegia | 1 | 2010 | 161 | 0.090 |
Why?
|
Politics | 1 | 2016 | 815 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2021 | 2330 | 0.080 |
Why?
|
Drug Resistance | 1 | 2015 | 1596 | 0.080 |
Why?
|
Wounds, Gunshot | 1 | 2015 | 582 | 0.080 |
Why?
|
Publication Bias | 1 | 2010 | 160 | 0.080 |
Why?
|
Patient Satisfaction | 2 | 2012 | 3462 | 0.080 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2014 | 621 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1600 | 0.080 |
Why?
|
Weight Gain | 2 | 2016 | 2348 | 0.080 |
Why?
|
Tumor Burden | 1 | 2015 | 1892 | 0.080 |
Why?
|
Parathyroid Hormone | 1 | 2015 | 1803 | 0.080 |
Why?
|
Proline | 1 | 2010 | 457 | 0.080 |
Why?
|
Endarterectomy | 1 | 2009 | 196 | 0.080 |
Why?
|
Pregnancy Outcome | 2 | 2010 | 2922 | 0.080 |
Why?
|
Intestines | 2 | 2017 | 1910 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2015 | 2057 | 0.080 |
Why?
|
Health Personnel | 1 | 2022 | 3335 | 0.080 |
Why?
|
Radial Artery | 1 | 2010 | 187 | 0.080 |
Why?
|
Biopsy | 1 | 2020 | 6766 | 0.080 |
Why?
|
Aortic Rupture | 1 | 2011 | 319 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2016 | 875 | 0.070 |
Why?
|
Phenotype | 3 | 2010 | 16592 | 0.070 |
Why?
|
Firearms | 1 | 2015 | 626 | 0.070 |
Why?
|
Mammaplasty | 1 | 2018 | 1239 | 0.070 |
Why?
|
Embolism | 1 | 2011 | 399 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3639 | 0.070 |
Why?
|
Child | 4 | 2018 | 80158 | 0.070 |
Why?
|
Vaginal Neoplasms | 1 | 2008 | 104 | 0.070 |
Why?
|
Mammography | 1 | 2018 | 2430 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2273 | 0.070 |
Why?
|
Body Composition | 1 | 2016 | 2426 | 0.070 |
Why?
|
Arginine | 1 | 2010 | 934 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2019 | 10212 | 0.070 |
Why?
|
Evidence-Based Medicine | 4 | 2010 | 3688 | 0.070 |
Why?
|
Epidemics | 1 | 2012 | 512 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 2024 | 0.060 |
Why?
|
Estrogens | 2 | 2009 | 1522 | 0.060 |
Why?
|
Premenopause | 1 | 2009 | 1039 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2015 | 1998 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2016 | 7828 | 0.060 |
Why?
|
Arterial Occlusive Diseases | 1 | 2009 | 748 | 0.060 |
Why?
|
Embryo Transfer | 1 | 2009 | 522 | 0.060 |
Why?
|
Adolescent | 5 | 2018 | 88326 | 0.060 |
Why?
|
Prosthesis Design | 4 | 2018 | 2115 | 0.060 |
Why?
|
Aneurysm | 1 | 2008 | 337 | 0.060 |
Why?
|
Reoperation | 1 | 2015 | 4303 | 0.060 |
Why?
|
Progesterone | 1 | 2009 | 742 | 0.060 |
Why?
|
Stroke | 4 | 2017 | 9758 | 0.060 |
Why?
|
Heart | 1 | 2017 | 4404 | 0.060 |
Why?
|
Young Adult | 6 | 2020 | 59260 | 0.060 |
Why?
|
Starvation | 2 | 2014 | 142 | 0.060 |
Why?
|
Phenylalanine | 2 | 2016 | 366 | 0.060 |
Why?
|
Permeability | 2 | 2017 | 723 | 0.060 |
Why?
|
Animals | 13 | 2021 | 168475 | 0.060 |
Why?
|
Health Status | 1 | 2016 | 4077 | 0.050 |
Why?
|
Leiomyoma | 1 | 2008 | 636 | 0.050 |
Why?
|
Infertility, Female | 1 | 2009 | 760 | 0.050 |
Why?
|
United States | 6 | 2018 | 72340 | 0.050 |
Why?
|
Lower Extremity | 1 | 2011 | 1202 | 0.050 |
Why?
|
Leadership | 1 | 2012 | 1385 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2012 | 20100 | 0.050 |
Why?
|
Anticoagulants | 1 | 2018 | 4812 | 0.050 |
Why?
|
Insulin Resistance | 1 | 2016 | 3964 | 0.050 |
Why?
|
Societies, Medical | 1 | 2014 | 3905 | 0.050 |
Why?
|
Germ-Line Mutation | 1 | 2010 | 1858 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 2014 | 2373 | 0.050 |
Why?
|
Thrombolytic Therapy | 1 | 2011 | 2064 | 0.050 |
Why?
|
Psychometrics | 1 | 2012 | 3065 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 15502 | 0.050 |
Why?
|
History, Ancient | 2 | 2012 | 212 | 0.050 |
Why?
|
Critical Illness | 1 | 2014 | 2723 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2011 | 2084 | 0.050 |
Why?
|
Cesarean Section | 1 | 2010 | 1398 | 0.050 |
Why?
|
Neoplasms | 1 | 2010 | 22173 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2017 | 4671 | 0.050 |
Why?
|
Postmenopause | 1 | 2009 | 2513 | 0.040 |
Why?
|
Kidney | 1 | 2016 | 7048 | 0.040 |
Why?
|
Surgical Fixation Devices | 1 | 2020 | 8 | 0.040 |
Why?
|
Regression Analysis | 1 | 2010 | 6345 | 0.040 |
Why?
|
Postoperative Period | 2 | 2015 | 1814 | 0.040 |
Why?
|
Blood Pressure | 1 | 2015 | 8481 | 0.040 |
Why?
|
Swine | 2 | 2021 | 5915 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4793 | 0.040 |
Why?
|
Gallbladder Neoplasms | 1 | 2021 | 189 | 0.040 |
Why?
|
Septal Occluder Device | 1 | 2020 | 125 | 0.040 |
Why?
|
Sternotomy | 1 | 2020 | 128 | 0.040 |
Why?
|
Quality of Life | 2 | 2017 | 13367 | 0.040 |
Why?
|
Azides | 1 | 2018 | 118 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5337 | 0.040 |
Why?
|
Click Chemistry | 1 | 2018 | 95 | 0.040 |
Why?
|
Prospective Studies | 2 | 2020 | 54423 | 0.040 |
Why?
|
Lipopolysaccharides | 2 | 2017 | 2206 | 0.040 |
Why?
|
Triglycerides | 2 | 2017 | 2461 | 0.040 |
Why?
|
Guided Tissue Regeneration | 1 | 2017 | 88 | 0.040 |
Why?
|
Biotransformation | 1 | 2016 | 166 | 0.030 |
Why?
|
Mesalamine | 1 | 2017 | 135 | 0.030 |
Why?
|
Ascitic Fluid | 1 | 2016 | 189 | 0.030 |
Why?
|
Hepatic Stellate Cells | 1 | 2017 | 119 | 0.030 |
Why?
|
Infant | 1 | 2018 | 36193 | 0.030 |
Why?
|
Administration, Oral | 2 | 2014 | 4021 | 0.030 |
Why?
|
Pituitary Diseases | 1 | 2016 | 135 | 0.030 |
Why?
|
Hypertension | 1 | 2015 | 8540 | 0.030 |
Why?
|
Logistic Models | 1 | 2010 | 13255 | 0.030 |
Why?
|
Lipogenesis | 1 | 2017 | 214 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4352 | 0.030 |
Why?
|
Child, Preschool | 1 | 2018 | 42232 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2015 | 14417 | 0.030 |
Why?
|
Morganella morganii | 1 | 2014 | 5 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8554 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9280 | 0.030 |
Why?
|
Streptomycin | 1 | 2014 | 69 | 0.030 |
Why?
|
Deoxyribonucleotides | 1 | 2014 | 43 | 0.030 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2015 | 327 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2017 | 603 | 0.030 |
Why?
|
Internship and Residency | 1 | 2014 | 5882 | 0.030 |
Why?
|
Hyperparathyroidism | 1 | 2015 | 337 | 0.030 |
Why?
|
Ampicillin | 1 | 2014 | 136 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2018 | 1085 | 0.030 |
Why?
|
Dysmenorrhea | 1 | 2015 | 98 | 0.030 |
Why?
|
Plant Extracts | 1 | 2017 | 497 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 540 | 0.030 |
Why?
|
Absorption | 1 | 2013 | 242 | 0.030 |
Why?
|
Subcutaneous Fat | 1 | 2016 | 393 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2017 | 1341 | 0.030 |
Why?
|
Azo Compounds | 1 | 2013 | 117 | 0.030 |
Why?
|
Age Factors | 1 | 2009 | 18399 | 0.030 |
Why?
|
Microvilli | 1 | 2013 | 234 | 0.030 |
Why?
|
Enterococcus faecalis | 1 | 2014 | 245 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11120 | 0.030 |
Why?
|
Jejunum | 1 | 2014 | 472 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2017 | 709 | 0.030 |
Why?
|
Pelvic Pain | 1 | 2015 | 298 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20568 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2014 | 225 | 0.020 |
Why?
|
Ileum | 1 | 2014 | 557 | 0.020 |
Why?
|
Models, Economic | 1 | 2015 | 716 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2016 | 613 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2016 | 1784 | 0.020 |
Why?
|
Remission Induction | 1 | 2017 | 2397 | 0.020 |
Why?
|
Thermogenesis | 1 | 2015 | 475 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2017 | 1164 | 0.020 |
Why?
|
Lung | 2 | 2021 | 10002 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2011 | 221 | 0.020 |
Why?
|
Ion Channels | 1 | 2015 | 1040 | 0.020 |
Why?
|
Rats | 2 | 2018 | 23741 | 0.020 |
Why?
|
Pyrroles | 1 | 2017 | 1125 | 0.020 |
Why?
|
Ethanol | 1 | 2017 | 1324 | 0.020 |
Why?
|
Cranial Nerve Injuries | 1 | 2010 | 28 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2016 | 999 | 0.020 |
Why?
|
Prognosis | 3 | 2018 | 29629 | 0.020 |
Why?
|
Atrophy | 1 | 2015 | 1633 | 0.020 |
Why?
|
Intestine, Small | 1 | 2016 | 1206 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 2018 | 1052 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 14033 | 0.020 |
Why?
|
Hepatocytes | 1 | 2017 | 1233 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5247 | 0.020 |
Why?
|
Prosthesis Fitting | 1 | 2010 | 75 | 0.020 |
Why?
|
Specialties, Surgical | 1 | 2014 | 389 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 976 | 0.020 |
Why?
|
Clomiphene | 1 | 2009 | 71 | 0.020 |
Why?
|
Radiography | 2 | 2011 | 6965 | 0.020 |
Why?
|
Liver | 2 | 2017 | 7528 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2643 | 0.020 |
Why?
|
Genes, bcl-2 | 1 | 2009 | 119 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2015 | 1722 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2014 | 1125 | 0.020 |
Why?
|
SEER Program | 1 | 2014 | 1450 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6312 | 0.020 |
Why?
|
DNA Primers | 1 | 2013 | 2820 | 0.020 |
Why?
|
Inguinal Canal | 1 | 2008 | 71 | 0.020 |
Why?
|
Patient Positioning | 1 | 2011 | 326 | 0.020 |
Why?
|
Piperidines | 1 | 2017 | 1656 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4576 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 2014 | 794 | 0.020 |
Why?
|
bcl-2-Associated X Protein | 1 | 2009 | 282 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2015 | 1733 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2009 | 335 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3549 | 0.020 |
Why?
|
Neck | 1 | 2012 | 734 | 0.020 |
Why?
|
Lymphocytes | 1 | 2015 | 2612 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 1989 | 0.020 |
Why?
|
Mice | 4 | 2017 | 81539 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2017 | 1868 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2495 | 0.020 |
Why?
|
Drug Costs | 1 | 2015 | 1183 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8181 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2010 | 15843 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2008 | 11461 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2014 | 1048 | 0.020 |
Why?
|
Thrombectomy | 1 | 2011 | 705 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2008 | 462 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10090 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3713 | 0.020 |
Why?
|
Perception | 1 | 2012 | 1197 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2009 | 1096 | 0.020 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2011 | 732 | 0.020 |
Why?
|
Motivation | 1 | 2015 | 2006 | 0.020 |
Why?
|
Up-Regulation | 1 | 2014 | 4125 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3322 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3465 | 0.020 |
Why?
|
Weight Loss | 1 | 2016 | 2684 | 0.020 |
Why?
|
Pyrimidines | 1 | 2017 | 3028 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2008 | 496 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13510 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 2010 | 882 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2009 | 1204 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2015 | 3313 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3201 | 0.010 |
Why?
|
Heart Failure | 1 | 2008 | 11671 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41495 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3725 | 0.010 |
Why?
|
Angiography | 1 | 2008 | 1595 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2735 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8633 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5493 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8466 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5429 | 0.010 |
Why?
|
Radiography, Interventional | 1 | 2009 | 1121 | 0.010 |
Why?
|
Blood Glucose | 1 | 2016 | 6391 | 0.010 |
Why?
|
Computer Simulation | 1 | 2015 | 6241 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7396 | 0.010 |
Why?
|
Anxiety | 1 | 2016 | 4573 | 0.010 |
Why?
|
Escherichia coli | 1 | 2014 | 4217 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8002 | 0.010 |
Why?
|
Equipment Design | 1 | 2009 | 3511 | 0.010 |
Why?
|
Health Expenditures | 1 | 2014 | 2366 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4948 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 2009 | 1420 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11530 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9177 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12723 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15266 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15601 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2009 | 1667 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11904 | 0.010 |
Why?
|
Depression | 1 | 2016 | 8126 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14665 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15733 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18255 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21355 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2009 | 5293 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10774 | 0.010 |
Why?
|
Apoptosis | 1 | 2010 | 9490 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 26129 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23447 | 0.010 |
Why?
|
Mutation | 1 | 2015 | 30053 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2008 | 39106 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36426 | 0.000 |
Why?
|